Attending rounds: An older patient with nephrotic syndrome

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 4, 2012, Pages 665-670

  Glassock, Richard J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; EVALUATION; HUMAN; IDIOPATHIC DISEASE; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; SYMPTOM;

AGE FACTORS; AGED; BIOLOGICAL MARKERS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; KIDNEY; LUNG NEOPLASMS; MALE; NEPHROTIC SYNDROME; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 84859526138     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.12771211     Document Type: Article

References (28)

1. Glassock RJ: Glomerular Disease in the Elderly Population. Nephrology and Geriatrics Integrated, edited by Oreopoulos DG, Hazzard WH, Luke R, Dordrecht, Netherlands, Kluwer Academic Publishers, 2000, pp 57-66
2. Oreopoulos DG, Glassock RJ, Jassal SV, O'Hare AM, Rosner MH, Swidler MA, Williams ME, Wiggins J: Geriatric nephrology. NephSAP 10: 43-52, 2011
3. Sethi S, Fervenza FC: Membranoproliferative glomerulonephritis: Pathogenetic heterogeneity and proposal for a new classification. Semin Nephrol 31: 341-348, 2011
4. Glassock RJ: Secondary minimal change disease. Nephrol Dial Transplant 18[Suppl 6]: vi52-vi58, 2003
5. Glassock RJ: Secondary membranous glomerulonephritis. Nephrol Dial Transplant 7[Suppl 1]: 64-71, 1992
6. Stiles KP, Hill C, Le Brun CJ, Reinmuth B, Yuan CM, Abbott KC: The impact of bleeding times on major complication rates after percutaneous real-time ultrasound-guided renal biopsies. J Nephrol 14: 275-279, 2001
7. Hofstra JM, Willems JL, Wetzels JF: Estimated glomerular filtration rate in the nephrotic syndrome. Nephrol Dial Transplant 26: 550-556, 2011
8. Markowitz GS, Falkowitz DC, Isom R, Zaki M, Imaizumi S, Appel GB, D'Agati VD: Membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxib. Clin Nephrol 59: 137-142, 2003
9. Lee JC, Yamauchi H, Hopper J Jr: The association of cancer and the nephrotic syndrome. Ann Intern Med 64: 41-51, 1966
10. Row PG, Cameron JS, Tuner DR, Evans DJ, White RH, Ogg CS, Chantler C, Brown CB: Membranous nephropathy. Long-term follow-up and association with neoplasia. QJ Med 44: 207-239, 1975
11. Eagen JW: Glomerulopathies of neoplasia. Kidney Int 11: 297-303, 1977
12. Morel-Maroger Striker L, Striker GE: Glomerular lesions in malignancies. Contrib Nephrol 48: 111-124, 1985
13. Brueggemeyer CD, Ramirez G: Membranous nephropathy: A concern for malignancy. Am J Kidney Dis 9: 23-26, 1987
14. Beck LH Jr: Membranous nephropathy and malignancy. Semin Nephrol 30: 635-644, 2010
15. Bjørneklett R, Vikse BE, Svarstad E, Aasarød K, Bostad L, Langmark F, Iversen BM: Long-term risk of cancer in membranous nephropathy patients. Am J Kidney Dis 50: 396-403, 2007
16. Hill AB: The environment and disease: Association or causation? Proc R Soc Med 58: 295-300, 1965
17. Lefaucheur C, Stengel B, Nochy D, Martel P, Hill GS, Jacquot C, Rossert J; GN-PROGRESS Study Group: Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association. Kidney Int 70: 1510-1517, 2006
18. Glassock RJ: Prophylactic anticoagulation in nephrotic syndrome: A clinical conundrum. J Am Soc Nephrol 18: 2221-2225, 2007
19. Lionaki S, K Derebail V, Hogan SL, Barbour S, Lee T, Hladunewich M, Greenwald A, Hu Y, Jennette CE, Jennette JC, Falk RJ, Cattran DC, Nachman PH, Reich HN: Venous thromboembolism in patients with membranous nephropathy. Clin J Am Soc Nephrol 7: 43-51, 2012
20. Couser WG, Wagonfeld JB, Spargo BH, Lewis EJ: Glomerular deposition of tumor antigen in membranous nephropathy associated with colonic carcinoma. Am J Med 57: 962-970, 1974
21. Lewis MG, Loughridge LW, Phillips TM: Immunological studies in nephrotic syndrome associated with extrarenal malignant disease. Lancet 298: 134-135, 1971
22. Beaufils H, Jouanneau C, Chomette G: Kidney and cancer: Results of immunofluorescence microscopy. Nephron 40: 303-308, 1985
23. Takeda S, Chinda J, Murakami T, Numata A, Iwazu Y, Akimoto T, Hamano Y, Muto S, Takahashi M, Kusano E: Development of features of glomerulopathy in tumor-bearing rates: A potential model for paraneoplastic glomerulopathy [published online ahead of print November 2, 2011]. Nephrol Dial Transplant doi:10.1093/ndt/gfr565
24. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361: 11-21, 2009
25. QinW, Beck LH Jr, Zeng C, Chen Z, Li S, Zuo K, Salant DJ, Liu Z: Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 22: 1137-1143, 2011
26. Stanescu HC, Arcos-Burgos M, Medlar A, Bockenhauer D, Kottgen A, Dragomirescu L, Voinescu C, Patel N, Pearce K, Hubank M, Stephens HA, Laundy V, Padmanabhan S, Zawadzka A, Hofstra JM, Coenen MJ, den Heijer M, Kiemeney LA, Bacq-Daian D, Stengel B, Powis SH, Brenchley P, Feehally J, Rees AJ, Debiec H, Wetzels JF, Ronco P, Mathieson PW, Kleta R: Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med 364: 616-626, 2011
27. Ohtani H, Wakui H, Komatsuda A, Okuyama S, Masai R, Maki N, Kigawa A, Sawada K, Imai H: Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant 19: 574-579, 2004
28. QuZ, LiuG, Li J, Wu LH, Tan Y, Zheng X, Ao J, ZhaoMH:Absence of glomerular IgG4 deposition in patients with membranous nephropathymay indicatemalignancy [published online ahead of print October 5, 2011]. Nephrol Dial Transplant doi:10.1093/ndt/gfr534